Clinical trialNACompleted
Trimodal Prehabilitation in Pancreatic Cancer Patients Urdergoing Neoadjuvant Treatment
Trimodal Prehabilitation in Pancreatic Cancer Patients Candidate to Neoadjuvant Treatment: A Pilot Study
- Outcome
- Finished, no results posted
- Phase
- NA
- Status
- Completed
- Study type
- Interventional
- Start
- 15 March 2022
- Expected end
- 9 May 2025
- Enrollment
- 14 participants
- Sites
- 1
- Primary outcomes
- To explore the feasibility of a trimodal prehabilitation program in the hospital setting
- Sponsor
- Other
- Results posted
- No
- Last update
- 4 June 2025
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.
Try
Papers 5
- BackgroundExercise efficacy and prescription during treatment for pancreatic ductal adenocarcinoma: a systematic review. DOI 10.1186/s12885-020-07733-0↗
- BackgroundPrehabilitation prior to surgery for pancreatic cancer: A systematic review. DOI 10.1016/j.pan.2020.07.411↗
- BackgroundThe Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resec… DOI 10.1245/s10434-019-08161-6↗
- BackgroundSarcopenia is a reliable prognostic factor in patients with advanced pancreatic cancer receiving FOLFIRINOX chemotherap… DOI 10.1016/j.pan.2018.11.001↗
- BackgroundPre-operative cardiopulmonary exercise testing predicts adverse post-operative events and non-progression to adjuvant t… DOI 10.1111/hpb.12060↗